Skip to main content
ES
v1.2
Log in
E

ERIS Lifescience

ERIS LIFESCIENCENSE
₹1,150+0.00 (+0.00%)
Market Cap
₹15,797Cr.
P/E Ratio
24.1
P/B Ratio
4.08
EPS (TTM)
₹47.72
Div Yield
0.63%
ROCE
14.1%
ROE
18.7%
52W Low: ₹1,13152W High: ₹1,740
Themes:💊 Pharma & CDMO
Appears in 2 screens
⬇️52-Week Low Watch
90
🔄Turnaround Watch
69
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 23.0% a year over three years.
  • Debt is 0.60× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

ERIS_Lifescience — Price
Interval
||
Style
Failed: 503

Evenstocks Score

Middle third
6.8/ 10Overall
7/ 10Valuation
6/ 10Quality
5/ 10Fundamental
9/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 24.1P/E: 24.1 | P/B: 4.08
Growth
GrowingSales CAGR — 3Y: 23% · 1Y: 10%
Profitability
ModerateROCE: 14.1% | ROE: 18.7%

Key Metrics

Valuation
PEG Ratio 1.27
Price / Sales 4.89x
Price / FCF 65.5x
Book Value ₹282
Margins & returns
Operating Margin 35%

Frequently Asked Questions

MarketsPortfolioChart